|
Title
|
Published
|
Price
|
|
Dealmaking and Industry Outlook: Neurological Disease
By: Decision Resources
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying
causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may
|
more...
|
11/2/2009
|
$2,250.00
|
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
By: BioSeeker Group AB
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
|
more...
|
10/29/2009
|
$3,500.00
|
|
Plunkett's Health Care Technologies Overview 2010 (Summary)
By: Plunkett Research, Ltd.
This summary contains the complete technologies section excerpted from the highly-acclaimed Plunkett's Health Care Industry Almanac. This report will be your ready-reference guide to new and developing health care technologies. Technology topics range from stem
|
more...
Search inside this report
|
10/16/2009
|
$199.99
|
|
The Human Genome Sequencing Center at Baylor College of Medicine Relies on Quantum's StorNext Software for Data Management
By: IDC
This IDC Buyer Case Study examines how one research institution utilizes Quantum's StorNext data management software to support its growing storage
|
more...
Search inside this report
|
10/8/2009
|
$3,500.00
|
|
Preventive Healthcare Technologies, Products and Markets
By: BCC Research
THIS REPORT:
Forecasts for the U.S. market in products and services, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014,
|
more...
Search inside this report
|
10/1/2009
|
$4,850.00
|
|
Transfection Life Science Dashboard™ Series 2
By: Percepta Associates, Inc.
The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard
|
more...
Search inside this report
|
10/1/2009
|
$3,850.00
|
|
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
By: Business Insights
Microarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a decade it is only recently that they have moved
|
more...
Search inside this report
|
10/1/2009
|
$3,835.00
|
|
Genealogy Products and Services
By: Global Industry Analysts
The global outlook series on Genealogy Products and Services provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird’s eye view of the industry; highlights latest
|
more...
|
10/1/2009
|
$950.00
|
|
Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2009-2018
By: Venture Planning Group
This report is an invaluable strategic planning resources for corporate, marketing and R&D executives. This report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include to
|
more...
|
10/1/2009
|
$11,800.00
|
|
Genetic Diseases and Dysmorphic Syndromes Turner's Syndrome Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Turner's Syndrome Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of turner's syndrome drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Genetic Diseases and Dysmorphic Syndromes Gaucher's Disease Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Gaucher's Disease Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of gaucher's disease drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Genetic Diseases and Dysmorphic Syndromes Wilson Disease Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Wilson Disease Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of wilson disease drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Biomarkers- Advanced Technologies and Global Market (2009-2014)
By: MarketsandMarkets
Report Description
The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and
|
more...
Buy by the section | Search inside this report
|
9/9/2009
|
$4,650.00
|
|
U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions
By: Fuji-Keizai USA, Inc.
DNA-based diagnostics are established in laboratory medicine with many of the top tests run for infectious disease. The U.S. market for DNA-based infectious disease tests is today a $1.1 billion industry. Nucleic acid testing (NAT)
|
more...
|
9/2/2009
|
$1,800.00
|
|
Diabetes R & D Pipeline: Cell and Stem Cell Therapies
By: BioPolaris
This report addresses the recent advances in research and development of pancreatic islet cell
and stem cell therapies for the treatment diabetes, primarily of type 1 diabetes. The
report features 10 cell and stem cell
|
more...
Search inside this report
|
9/1/2009
|
$650.00
|
|
Uncovering Biomarker and Diagnostic Opportunities in Immune and Inflammatory Diseases
By: Decision Resources
Introduction
Despite the robust drug market for immune and infl ammatory diseases and their high prevalence, diagnostics associated
with these diseases do not constitute a large marketplace. Although researchers are working to discover
biomarkers, associate
|
more...
|
8/21/2009
|
$2,250.00
|
|
Neurological Disease: Early-Stage R&D and Dealmaking
By: Decision Resources
Introduction
How can early-stage R&D efforts be positioned to tap the remaining opportunity in the neurology
drug market? Although brimming with potential, neurology drug development is also rife with unique
challenges that many companies and
|
more...
|
8/20/2009
|
$2,250.00
|
|
Plunkett's Biotech & Genetics Industry Trends & Statistics 2010 (Summary)
By: Plunkett Research, Ltd.
This carefully-researched report will be your ready-reference guide to the Biotechnology and Genetics Industry. Excerpted from Plunkett's Biotech and Genetics Industry Almanac, this summary includes our analysis of the major trends, from the convergence of
|
more...
Search inside this report
|
8/14/2009
|
$199.99
|
|
Plunkett's Biotech & Genetics Industry Almanac 2010
By: Plunkett Research, Ltd.
Plunkett's Biotech & Genetics Industry Almanac is a complete reference guide to the business side of biotechnology, genetics, proteomics and related services. This new book contains complete profiles of the leading biotech companies, in-depth chapters
|
more...
Search inside this report
|
8/14/2009
|
$299.99
|
|
DNA Sequencing Equipment and Services Markets, 2nd Edition
By: Kalorama Information
Since the last edition of Kalorama Information's DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the
|
more...
Search inside this report
|
8/1/2009
|
$3,800.00
|
|
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach
By: Business Insights
Introduction
Against a background of increasing commercial pressures the need to find new markets and exploit them has never been greater. At the same time changes in prevailing healthcare thinking with respect to the
|
more...
Search inside this report
|
8/1/2009
|
$3,835.00
|
|
Bioarrays for Life Science Research, Diagnostics and Drug R&D
By: Takeda Pacific
This research report is about the worldwide bioarray tools, technologies and services market. Bioarrays are also known as DNA microarrays, protein arrays, or biochips. These key mainstream life science research products and services involve technologies
|
more...
|
8/1/2009
|
$2,495.00
|
|
Strategic Analysis of U.S. Molecular Cytogenetics Markets
By: Frost & Sullivan
This research service provides a strategic analysis of the molecular cytogenetics market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key challenges
|
more...
|
7/14/2009
|
$6,000.00
|
|
Personalized Medicine: Technologies and the Global Market
By: BCC Research
This Report:
Provides an in-depth look at the global market for personalized medicine
Measures the diagnostic market segment for personalized medicine, focusing on its high growth rate
Offers current market data and
|
more...
Search inside this report
|
7/1/2009
|
$4,850.00
|
|
Small Molecule Kinase Inhibitors
By: Global Industry Analysts
This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. Annual forecasts are provided for the
|
more...
|
7/1/2009
|
$3,950.00
|
|
Title
|
Published
|
Price
|
(0 items)
